Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE DOSES THAT MAY BE USED IN THE EVENT OF AN OUTBREAK SCENARIO. THE PROPOSED EFFORT WILL UTILI | ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | $240,940,070 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN42HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | Dec 29, 2022 | Dec 29, 2022 | Sep 30, 2030 | ||
| THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. | ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | $149,747,956 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | — | 541714Research and Development in Biotechnology (except Nanobiotechnology) | AN73 | Sep 26, 2019 | Sep 26, 2019 | Sep 30, 2027 |